obesity treatment with bariatric surgery vs glp-1 receptor agonists 'superior' for countering weight regain after GLP-1 Drugs vs. Bariatric Surgery
Description
Endocrinology (2015) 156(10):355969
lixisenatide), LEADER (Liraglutide Effects and Action in Diabetes: Evaluation of cardiovascular outcome Results
Hepatology (2017) 66(3):80924
Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats
Researchers identified adults who used GLP-1 receptor agonists and DPP-IV inhibitors and obtained the duration of use in the 6 years before the lag time
Konig M, Riddle MC, Colhoun HM, et al
